ARTICLE
27 November 2019

The Quid Pro Quo Failing Biodiversity And The Discovery Of New Products

W
WilmerHale

Contributor

WilmerHale provides legal representation across a comprehensive range of practice areas critical to the success of its clients. With a staunch commitment to public service, the firm is a leader in pro bono representation. WilmerHale is 1,000 lawyers strong with 12 offices in the United States, Europe and Asia.
WilmerHale Partner Bruce Manheim has written an opinion piece that was published in the journal BioScience, volume 69, issue 11, November 2019, pages 856–857.
United States Food, Drugs, Healthcare, Life Sciences

WilmerHale Partner Bruce Manheim has written an opinion piece that was published in the journal BioScience, volume 69, issue 11, November 2019, pages 856–857. An excerpt:

"With enormous technological advances in genomics and other disciplines, biodiversity represents a wealth of untapped genetic information potentially leading to additional breakthroughs. But progress in this area is being stymied, if not paralyzed, by a dysfunctional international legal system that governs the access to and the use of biological resources. This problem is now growing worse as many countries implement this legal system with the passage of new national laws and regulations to govern the use of biological resources for research and development..."

Read the abstract of his article, which is available by subscription or payment.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More